Sohomoy
Companion Diagnostics for Oncology Market: Revolutionizing Liquid Biopsy Assays, Multiplex NGS, and Clinical Workflows
Surging global incidence of solid and hematological malignancies, expanding biopharmaceutical investment in targeted oncology therapies and immunotherapies, and continuous molecular diagnostic innovations in next-generation sequencing (NGS) and liquid biopsy assays are driving rapid growth across the global Companion Diagnostics for Oncology Market. Companion diagnostics (CDx) for oncology...
16 Views